scholarly journals SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors

2021 ◽  
Author(s):  
Judith Leon ◽  
Anna Merrill ◽  
Kai Rogers ◽  
Julie Kurt ◽  
Spencer Dempewolf ◽  
...  
Keyword(s):  
Antibody Level ◽  
Plasma Volume ◽  
Single Unit ◽  
Antibody Responses ◽  
Plasma Samples ◽  
High Antibody ◽  
Before And After ◽  
Antibody Levels ◽  
Very High

Background and Objectives: Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to examine patient antibody responses following COVID-19 Convalescent Plasma (CCP) transfusion and compare responses to CCP from vaccinated and nonvaccinated donors. Materials and methods: Plasma samples were obtained from 25 recipients of CCP and COVID-19 antibody levels measured before and after CCP treatment. Factors that effect antibody levels were examined. Results: In the 21 patients who received CCP from nonvaccinated donors, only modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with remarkable accuracy. In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. Conclusion: If available, CCP from vaccinated donors with very high antibody levels should be used. CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.

scholarly journals Direct Comparison of Antibody Responses to Four SARS-CoV-2 Vaccines in Mongolia

2021 ◽  
Author(s):  
Naranjargal J. Dashdorj ◽  
Oliver F. Wirz ◽  
Katharina Roeltgen ◽  
Emily Haraguchi ◽  
Anthony S. Buzzanco ◽  
...  
Keyword(s):  
Antibody Responses ◽  
Health Interventions ◽  
High Antibody ◽  
Antibody Testing ◽  
Public Health Interventions ◽  
Vaccine Responses ◽  
Blocking Activity ◽  
Antibody Titers ◽  
Alpha Variant ◽  
Antibody Levels

Different vaccines for SARS-CoV-2 are approved in various countries, but few direct comparisons of the antibody responses they stimulate have been reported. We collected plasma specimens in July 2021 from 196 Mongolian participants fully vaccinated with one of four Covid vaccines: Pfizer/BioNTech, AstraZeneca, Sputnik V and Sinopharm. Functional antibody testing with a panel of nine SARS-CoV-2 viral variant RBD proteins reveal marked differences in the vaccine responses, with low antibody levels and RBD-ACE2 blocking activity stimulated by the Sinopharm and Sputnik V vaccines in comparison to the AstraZeneca or Pfizer/BioNTech vaccines. The Alpha variant caused 97% of infections in Mongolia in June and early July 2021. Individuals who recover from SARS-CoV-2 infection after vaccination achieve high antibody titers in most cases. These data suggest that public health interventions such as vaccine boosting, potentially with more potent vaccine types, may be needed to control the COVID-19 pandemic in Mongolia and worldwide.

scholarly journals Neutralizing antibody response in non-hospitalized SARS-CoV-2 patients

2020 ◽  
Author(s):  
Natalia Ruetalo ◽  
Ramona Businger ◽  
Karina Althaus ◽  
Simon Fink ◽  
Felix Ruoff ◽  
...  
Keyword(s):  
Antibody Response ◽  
Western Blot ◽  
Neutralizing Antibody ◽  
Antibody Responses ◽  
Virus Neutralization ◽  
Surrogate Markers ◽  
High Antibody ◽  
Serological Survey ◽  
Course Of Disease ◽  
Antibody Levels

The majority of infections with SARS-CoV-2 are asymptomatic or mild without the necessity of hospitalization. It is of importance to reveal if these patients develop an antibody response against SARS-CoV-2 and to define which antibodies confer virus neutralization. We conducted a comprehensive serological survey of 49 patients with a mild course of disease and quantified neutralizing antibody responses against a clinical SARS-CoV-2 isolate employing human cells as targets. Four patients (8%), even though symptomatic, did not develop antibodies against SARS-CoV-2 and two other patients (4%) were only positive in one of the six serological assays employed. For the remainder, antibody response against the S-protein correlated with serum neutralization whereas antibodies against the nucleocapsid were poor predictors of virus neutralization. Regarding neutralization, only six patients (12%) could be classified as highly neutralizers. Furthermore, sera from several individuals with fairly high antibody levels had only poor neutralizing activity. In addition, employing a novel serological Western blot system to characterize antibody responses against seasonal coronaviruses, we found that antibodies against the seasonal coronavirus 229E might contribute to SARS-CoV-2 neutralization. Altogether, we show that there is a wide breadth of antibody responses against SARS-CoV-2 in patients that differentially correlate with virus neutralization. This highlights the difficulty to define reliable surrogate markers for immunity against SARS-CoV-2.

scholarly journals Can individuals with low antibody responses to vaccines against other viruses acquire adequate SARS-CoV-2 antibody after vaccination with the BNT162b2 mRNA vaccine?

2021 ◽  
Author(s):  
Wataru Ogura ◽  
Kouki Ohtsuka ◽  
Sachiko Matsuura ◽  
Takahiro Okuyama ◽  
Satsuki Matsushima ◽  
...  
Keyword(s):  
Cohort Study ◽  
Neutralizing Antibodies ◽  
Healthcare Workers ◽  
Neutralizing Antibody ◽  
Antibody Responses ◽  
Antibody Activity ◽  
Low Responders ◽  
Before And After ◽  
Positive Threshold ◽  
Antibody Levels

Objective In Japan, healthcare workers (HCWs) are vaccinated against coronavirus disease (COVID-19) and other contagious viruses (measles, rubella, chickenpox, mumps, and hepatitis B) to prevent nosocomial infection. However, some do not produce sufficient antibodies after vaccination (low responders). This study investigated changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody levels among HCWs after SARS-CoV-2 vaccination and assessed whether low responders produced adequate SARS-CoV-2 anti-spike and neutralizing antibodies. Methods We conducted a prospective cohort study of HCWs before and after vaccination with the BNT162b2 mRNA vaccine in a hospital in Tokyo, Japan. The HCWs received two doses of BNT162b2 vaccine, 3 weeks apart. Those whose antibody levels against previous antiviral vaccines did not reach protective antibody levels after receiving two doses were defined as low responders, whereas those who produced adequate antibodies were defined as normal responders. SARS-CoV-2 anti-spike antibodies were measured 11 times from before the first BNT162b2 vaccination to 5 months after the second vaccination. SARS-CoV-2 neutralizing antibody activity was measured twice in low responders, 1 week to 1 month and 5 months after the second vaccination. Results Fifty HCWs were included in the analytic cohort. After vaccination, SARS-CoV-2 anti-spike antibody was detectable in the samples from both responders at each timepoint, but the level was lower at 5 months than at 1 week after the second vaccination. Low responders had SARS-CoV-2 neutralizing antibody activity 1 week to 1 month after the second vaccination, which exceeded the positive threshold after 5 months. Conclusion After BNT162b2 vaccination, low responders acquired adequate SARS-CoV-2 anti-spike and SARS-CoV-2 neutralizing antibodies to prevent SARS-CoV-2. However, SARS-CoV-2 anti-spike antibody levels were lower at 5 months than at 1 week after the second dose of BNT162b2 vaccine in low and normal responders. Therefore, low responders should also receive a third dose of BNT162b2 vaccine.

scholarly journals Long-Lasting Protective Immune Response to the 19-Kilodalton Carboxy-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 in Mice

2007 ◽  
Vol 14 (4) ◽  
pp. 342-347 ◽  
Author(s):  
Pimmada Jeamwattanalert ◽  
Yuvadee Mahakunkijcharoen ◽  
Leera Kittigul ◽  
Pakpimol Mahannop ◽  
Sathit Pichyangkul ◽  
...  
Keyword(s):  
Immune Response ◽  
Antibody Level ◽  
Surface Protein ◽  
Merozoite Surface Protein ◽  
Plasmodium Yoelii ◽  
Antibody Responses ◽  
Igg2a Antibody ◽  
Igg1 Antibody ◽  
Merozoite Surface Protein 1 ◽  
Antibody Levels

ABSTRACT Merozoite surface protein 1 (MSP1) is the major protein on the surface of the plasmodial merozoite, and its carboxy terminus, the 19-kDa fragment (MSP119), is highly conserved and effective in induction of a protective immune response against malaria parasite infection in mice and monkeys. However, the duration of the immune response has not been elucidated. As such, we immunized BALB/c mice with a standard four-dose injection of recombinant Plasmodium yoelii MSP119 formulated with Montanide ISA51 and CpG oligodeoxynucleotide (ODN) and monitored the MSP119-specific antibody levels for up to 12 months. The antibody titers persisted constantly over the period of time without significant waning, in contrast to the antibody levels induced by immunization with Freund's adjuvant, where the antibody levels gradually declined to significantly lower levels 12 months after immunization. Investigation of immunoglobulin G (IgG) subclass longevity revealed that only the IgG1 antibody level (Th2 type-driven response) decreased significantly by 6 months, while the IgG2a antibody level (Th1 type-driven response) did not change over the 12 months after immunization, but the boosting effect was seen in the IgG1 antibody responses but not in the IgG2a antibody responses. After challenge infection, all immunized mice survived with negligibly patent parasitemia. These findings suggest that protective immune responses to MSP119 following immunization using oil-based Montanide ISA51 and CpG ODN as an adjuvant are very long-lasting and encourage clinical trials for malaria vaccine development.

scholarly journals Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021

2021 ◽  
Vol 26 (12) ◽  
Author(s):  
Sathyavani Subbarao ◽  
Lenesha A Warrener ◽  
Katja Hoschler ◽  
Keith R Perry ◽  
Justin Shute ◽  
...  
Keyword(s):  
Immune Response ◽  
United Kingdom ◽  
Single Dose ◽  
Antibody Responses ◽  
Antibody Assay ◽  
Antibody Levels ◽  
Very High

Sera were collected from 185 adults aged ≥ 70 years in London to evaluate the immune response to COVID-19 vaccines. A single dose of Pfizer/BioNtech vaccine resulted in > 94% seropositivity after 3 weeks in naïve individuals using the Roche Spike antibody assay, while two doses produced very high spike antibody levels, significantly higher than convalescent sera from mild-to-moderate PCR-confirmed adult cases. Our findings support the United Kingdom’s approach of prioritising the first dose and delaying the second dose of COVID-19 vaccine.

Immunofluorescent studies in filariasis: antibody levels in rats infected with the Malayan forest filaria, Breinlia booliati

1980 ◽  
Vol 54 (2) ◽  
pp. 155-160
Author(s):  
Mulkit Singh ◽  
G. B. Kane ◽  
Eu-Hian Yap ◽  
Beng-Chuan Ho ◽  
Joon-Wah Mak ◽  
...  
Keyword(s):  
Adult Worm ◽  
High Antibody ◽  
Antibody Technique ◽  
Immunofluorescent Antibody ◽  
Antibody Levels ◽  
Indirect Immunofluorescent ◽  
Very High ◽  
Adult Worm Antigen

ABSTRACTAntibody levels were investigated in rats infected with Breinlia booliati using the indirect immunofluorescent antibody technique. Sonicated antigens were prepared from microfilariae and adult worms. Adult worm antigen was rather unsatisfactory. The sonicated microfilarial antigen was useful in detecting antibodies in various groups of rat sera. Very high antibody levels were seen in amicrofilaraemic rats harbouring unisexual infections of varying worm loads. The singnificance of these observations are discussed.

scholarly journals Antibiotics Modulate Vaccine-Induced Humoral Immune Response

1999 ◽  
Vol 6 (6) ◽  
pp. 832-837 ◽  
Author(s):  
Patrick C. Y. Woo ◽  
Hoi-Wah Tsoi ◽  
Lei-Po Wong ◽  
Harry C. H. Leung ◽  
Kwok-Yung Yuen
Keyword(s):  
Immune Response ◽  
T Cell ◽  
Antibody Level ◽  
Tetanus Toxoid ◽  
Humoral Immune Response ◽  
Polysaccharide Vaccine ◽  
Antibody Responses ◽  
Pneumococcal Polysaccharide Vaccine ◽  
Humoral Immune ◽  
Antibody Levels

ABSTRACT The effects of antibiotics on the antigen-specific humoral immune response are not known. Macrolides, tetracyclines, and beta-lactams are commonly prescribed antibiotics. The first two are known to have immunomodulatory activities. The effects of clarithromycin, doxycycline, and ampicillin on the primary and secondary antibody responses to tetanus toxoid, a pneumococcal polysaccharide vaccine, a hepatitis B virus surface antigen (HBsAg) vaccine, and live attenuatedSalmonella typhi (Ty21a) were investigated using a mouse model. For the mice receiving the tetanus toxoid, the immunoglobulin M (IgM) level of the clarithromycin group at day 7 was significantly lower than the corresponding antibody level of the normal saline (NS) group. For the mice receiving the pneumococcal polysaccharide vaccine, the total antibody and IgM levels of the clarithromycin group and the IgM level of the doxycycline group at day 7 were significantly lower than the corresponding antibody levels of the ampicillin and NS groups. For the mice receiving the HBsAg vaccine, the IgM level of the doxycycline group at day 7 was significantly lower than the corresponding antibody levels of the clarithromycin and NS groups, while the IgM level of the clarithromycin group at day 28 was significantly lower than the corresponding antibody levels of the doxycycline, ampicillin, and NS groups. For the mice receiving all three vaccines, there were no statistically significant differences between any of the antibody levels of the ampicillin group and the corresponding antibody levels of the NS group. For the mice receiving Ty21a, the total antibody levels of the ampicillin group at days 7 and 21 were significantly higher than the corresponding antibody levels of the NS group. Moreover, the IgM levels of the clarithromycin, doxycycline, and ampicillin groups at days 7 and 21 were significantly higher than the corresponding antibody levels of the NS group. Furthermore, the total antibody level of the ampicillin group at day 21 was significantly higher than the corresponding antibody level of the doxycycline group. For all four vaccines, there were no statistically significant differences among the serum levels of interleukin-10 and gamma interferon for the mice treated with the various antibiotics. We conclude that clarithromycin and doxycycline, but not ampicillin, suppress the antibody responses of mice to T-cell-dependent and T-cell-independent antigens, whereas all three antibiotics enhance the antibody response to live attenuated mucosal bacterial vaccines.

scholarly journals High Levels of Antibodies to Multiple Domains and Strains of VAR2CSA Correlate with the Absence of Placental Malaria in Cameroonian Women Living in an Area of High Plasmodium falciparum Transmission

2012 ◽  
Vol 80 (4) ◽  
pp. 1479-1490 ◽  
Author(s):  
Yeung L. Tutterrow ◽  
Marion Avril ◽  
Kavita Singh ◽  
Carole A. Long ◽  
Robert J. Leke ◽  
...  
Keyword(s):  
Plasmodium Falciparum ◽  
Chondroitin Sulfate ◽  
Malaria Transmission ◽  
Placental Malaria ◽  
Plasma Samples ◽  
High Antibody ◽  
Allelic Variants ◽  
Increased Risk ◽  
Antibody Levels ◽  
Chondroitin Sulfate A

ABSTRACTPlacental malaria, caused by sequestration ofPlasmodium falciparum-infected erythrocytes in the placenta, is associated with increased risk of maternal morbidity and poor birth outcomes. The parasite antigen VAR2CSA (variant surface antigen 2-chondroitin sulfate A) is expressed on infected erythrocytes and mediates binding to chondroitin sulfate A, initiating inflammation and disrupting homeostasis at the maternal-fetal interface. Although antibodies can prevent sequestration, it is unclear whether parasite clearance is due to antibodies to a single Duffy binding-like (DBL) domain or to an extensive repertoire of antibodies to multiple DBL domains and allelic variants. Accordingly, plasma samples collected longitudinally from pregnant women were screened for naturally acquired antibodies against an extensive panel of VAR2CSA proteins, including 2 to 3 allelic variants for each of 5 different DBL domains. Analyses were performed on plasma samples collected from 3 to 9 months of pregnancy from women living in areas in Cameroon with high and low malaria transmission. The results demonstrate that high antibody levels to multiple VAR2CSA domains, rather than a single domain, were associated with the absence of placental malaria when antibodies were present from early in the second trimester until term. Absence of placental malaria was associated with increasing antibody breadth to different DBL domains and allelic variants in multigravid women. Furthermore, the antibody responses of women in the lower-transmission site had both lower magnitude and lesser breadth than those in the high-transmission site. These data suggest that immunity to placental malaria results from high antibody levels to multiple VAR2CSA domains and allelic variants and that antibody breadth is influenced by malaria transmission intensity.

scholarly journals Placental Malaria Diminishes Development of Antibody Responses to Plasmodium falciparum Epitopes in Infants Residing in an Area of Western Kenya Where P. falciparum Is Endemic

2005 ◽  
Vol 12 (3) ◽  
pp. 375-379 ◽  
Author(s):  
Phillip Cullison Bonner ◽  
Zhiyong Zhou ◽  
Lisa B. Mirel ◽  
John G. Ayisi ◽  
Ya Ping Shi ◽  
...  
Keyword(s):  
Plasmodium Falciparum ◽  
Immune Responses ◽  
Immunoglobulin G ◽  
Placental Malaria ◽  
Antibody Responses ◽  
Plasma Samples ◽  
Western Kenya ◽  
The Difference ◽  
Antibody Levels

ABSTRACT To determine the effect of placental malaria (PM) infection on the development of antibody responses to malaria in infants, we measured immunoglobulin G levels to seven different Plasmodium falciparum epitopes by using plasma samples collected at monthly intervals from infants born to mothers with and without PM. Overall, PM was associated with diminished antibody levels to all of the epitopes tested, especially with infants aged ≥4 to 12 months, and the difference was statistically significant for four of the seven epitopes (P < 0.0035). These findings suggest that PM can negatively influence the development of immune responses to malaria in infants.

Haemostatic response to hypoxaemic/exercise stress: the dilemma of plasma volume correction: Figure 1

2011 ◽  
Vol 64 (3) ◽  
pp. 269-271 ◽  
Author(s):  
Lewis Fall ◽  
Kevin A Evans ◽  
Michael H Lewis ◽  
Damian M Bailey
Keyword(s):  
Plasma Volume ◽  
Maximal Exercise ◽  
Arterial Occlusive Disease ◽  
Exercise Stress ◽  
Plasma Samples ◽  
Absolute Concentration ◽  
Exercise Challenge ◽  
Before And After ◽  
Volume Shift ◽  
Venous Plasma

ObjectivePatients with arterial occlusive disease are typically hypoxaemic, and exercise is prescribed for rehabilitation. Both stressors independently contract plasma volume (PV), which may influence clinical interpretation of a patient's thrombogenicity. The aim of the study was to emphasise the conceptual significance of PV correction.Methods and ResultsVenous plasma samples were obtained from 18 healthy men at rest in normoxia for the measurement of fibrinogen, prothrombin (PT), thrombin (TT) and activated partial thromboplastin (aPTT) times. Additional samples were obtained in hypoxia (12% oxygen) after 6 h of rest and immediately after a maximal exercise challenge. Haemostatic parameters were expressed before and after volume-shift correction. Passive hypoxia reduced PV by 3±5% (p<0.05 vs normoxia), with a further decrease observed during exercise (14±5%, p<0.05). The latter increased the absolute concentration of fibrinogen and shortened aPTT (p<0.05), but these changes were no longer apparent after PV correction (p>0.05). Likewise, the lack of change in absolute values for PT and TT (p>0.05) translated into an elongation after correction (p<0.05).ConclusionsThese findings highlight the important, but previously ignored, interpretive implications of PV correction when haemostasis is assessed.

Sign in / Sign up

Export Citation Format

Share Document